News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Nektar Therapeutics
NEWS
JOBS
IN THE PRESS
NEWS
BioMidwest
3 Biotech Stocks That Exploded in 2017
Rick Duprey, writing for The Motley Fool, takes a look at three biotech stocks that have quadrupled this year.
December 5, 2017
·
2 min read
·
Mark Terry
Biotech Bay
3 Biotechs That Have Investors Grinning at Thanksgiving Dinner This Year
Investors have had a decent year, but some have much to be grateful for this Thanksgiving.
November 21, 2017
·
3 min read
·
Mark Terry
Business
Bay Area’s Nektar Inks $400 Million+ Autoimmune Disease Pact With Eli Lilly
July 24, 2017
·
3 min read
Biotech Bay
Bay Area Nektar’ Comeback is Stalled as the EMA Rejects Breast Cancer Drug
July 21, 2017
·
2 min read
Biotech Bay
Nektar Therapeutics: A Sweet Or Sour Investment?
June 15, 2017
·
1 min read
Drug Development
For Sale: Nektar Therapeutics Plans to License Hot New Opioid Drug
March 20, 2017
·
3 min read
Drug Development
Nektar Therapeutics To Present At Jefferies Autumn 2015 Global Healthcare Conference In London
November 17, 2015
·
2 min read
Drug Development
Nektar Therapeutics Chief Science Officer Provides Details on Immuno-Oncology, Pain Pipelines
October 9, 2015
·
4 min read
Business
EXCLUSIVE: Nektar Therapeutics, University of Texas MD Anderson Cancer Center Team Up on Phase 1/2 Trial of NKTR-214
June 2, 2015
·
5 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Nektar Therapeutics Reports Third Quarter 2022 Financial Results
November 3, 2022
·
14 min read
Business
Nektar to Announce Financial Results for the Third Quarter 2022 on Thursday, November 3, 2022, After Close of U.S.-Based Financial Markets
October 25, 2022
·
1 min read
Biotech Bay
Nektar Therapeutics Presents Data for Rezpegaldesleukin (LY3471851) in Patients with Atopic Dermatitis and Psoriasis from Two Separate Clinical Studies at 2022 European Academy of Dermatology (EADV) Congress
September 7, 2022
·
7 min read
Drug Development
Nektar and Collaborators Announce Preclinical Publication of Data for NKTR-255 and its Observed Improvement of NK Cell Function in Multiple Myeloma
August 16, 2022
·
7 min read
Business
Nektar Therapeutics Reports Second Quarter 2022 Financial Results
August 4, 2022
·
12 min read
Business
Nektar to Announce Financial Results for the Second Quarter 2022 on Thursday, August 4, 2022, After Close of U.S.-Based Financial Markets
July 26, 2022
·
1 min read
Biotech Bay
Nektar Announces Promotion of Jillian B. Thomsen to Senior Vice President & Chief Financial Officer
July 1, 2022
·
5 min read
Business
Nektar Therapeutics Reports First Quarter 2022 Financial Results
May 5, 2022
·
9 min read
Biotech Bay
Nektar Therapeutics Announces Strategic Reorganization Plan and Corporate Outlook
April 25, 2022
·
9 min read
Drug Development
Nektar and Collaborators Present Preclinical Data on NKTR-255, a Novel IL-15 Receptor Agonist, in combination with CAR Cell Therapies at the 2022 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR®
April 23, 2022
·
8 min read
